Program Monitoring
7,103
Number of Clinics
57,892
Number of Settlements
5,399,046
Enrollments
23,117,636
Disbursements
Bauchi
1,110
9,861
760,061
3,311,800
Gombe
520
5,440
348,237
1,504,285
Jigawa
793
7,661
954,362
4,435,864
Kaduna
276
2,201
226,124
893,421
Kano
1,263
11,999
1,069,021
4,395,844
Katsina
1,299
6,847
1,120,734
5,155,534
Kebbi
545
3,168
242,835
944,698
Niger
484
3,417
73,564
142,307
Sokoto
380
3,024
217,046
840,442
Yobe
160
1,912
56,339
122,423
Zamfara
273
2,362
330,723
1,371,018
Vaccination Rate
95.79%
Penta 1
91.45%
Penta 2
88.53%
Penta 3
86.01%
Measles
Bauchi
95.61%
91.65%
88.95%
85.98%
Gombe
96.38%
92.99%
90.43%
87.15%
Jigawa
95.93%
92.7%
90.69%
88.1%
Kaduna
95.79%
91.23%
87.87%
83.89%
Kano
95.21%
91.26%
88.44%
85.64%
Katsina
96.65%
93.3%
91.05%
88.78%
Kebbi
94.9%
88.46%
84.1%
81.68%
Niger
94.38%
85.56%
78.23%
78.23%
Sokoto
94.05%
83.88%
77.85%
74.25%
Yobe
96.1%
90.27%
84.05%
83.54%
Zamfara
96.32%
88.78%
83.92%
83.44%
Impact Evaluation Key Findings
An independent randomized controlled trial found, among other positive findings, that New Incentives’ All Babies program:
Increased Coverage
The program doubled the percentage of infants who were fully vaccinated, increasing coverage from roughly a quarter to just over half of all infants.
Improved Timeliness
Infants who received measles vaccines were 33 percentage points more likely to receive the vaccine within one month of the recommended age.
Improved Knowledge and Attitudes
Caregivers in areas served by the program had better knowledge and more favorable attitudes toward immunization.
Reduced Stockouts
Government clinics with the program were 18 percentage points less likely to report vaccine stockouts during the last 12 months.
Randomized Controlled Trial
Expected in Dec 2020
Study with two-arm cluster RCT
- Control (83 clinics): No intervention, status quo
- Treatment (84 clinics): New Incentives full program
- This design will measure the causal effect of New Incentives' program on the likelihood of an infant receiving a vaccine.
.svg)
.svg)
.png)